Ally Bridge Group (NY) LLC Quant / Systematic

Location: New York, NY

CIK: 0001822947 · Show all filings

Period: Q4 2023 (← Previous) (Next →)

Filing Date: Feb 14, 2024

Total Value: $168M (100.0% shares, 0.0% debt)

Holdings (22)

— JASPER THERAPEUTICS INC 17.2%

Value $28.87M Shares 3,659,255 Est. Cost $2.48 Unrealized —

ARGX ARGENX SE - ADR 7.9%

Value $13.32M Shares 35,000 Est. Cost $380.43 Unrealized —

SLNO SOLENO THERAPEUTICS INC 7.4%

Value $12.48M Shares 309,950 Est. Cost $28.45 Unrealized 0.0%

— CYMABAY THERAPEUTICS INC 6.9%

Value $11.57M Shares 489,938 Est. Cost $23.62 Unrealized —

XENE XENON PHARMACEUTICALS INC 6.6%

Value $11.14M Shares 241,961 Est. Cost $36.94 Unrealized -4.4%

— INTRA-CELLULAR THERAPIES INC 6.0%

Value $10.12M Shares 141,348 Est. Cost $52.09 Unrealized —

OLMA OLEMA PHARMACEUTICALS INC 5.5%

Value $9.246M Shares 659,035 Est. Cost $13.44 Unrealized 0.0%

APLS APELLIS PHARMACEUTICALS INC 5.4%

Value $8.979M Shares 150,000 Est. Cost $43.93 Unrealized +15.5%

MLTX MOONLAKE IMMUNOTHERAPEUTICS 5.2%

Value $8.665M Shares 143,479 Est. Cost $37.06 Unrealized +39.1%

AXSM AXSOME THERAPEUTICS INC 4.8%

Value $8.028M Shares 100,862 Est. Cost $74.75 Unrealized -10.6%

— MERUS NV 4.5%

Value $7.56M Shares 274,923 Est. Cost $20.59 Unrealized —

— ALPINE IMMUNE SCIENCES INC 4.1%

Value $6.81M Shares 357,271 Est. Cost $19.06 Unrealized —

GERN GERON CORP 3.7%

Value $6.27M Shares 2,971,639 Est. Cost $2.61 Unrealized -25.6%

— AMBRX BIOPHARMA INC 3.3%

Value $5.488M Shares 385,383 Est. Cost $14.24 Unrealized —

— AVADEL PHARMACEUTICALS-ADR 2.9%

Value $4.9M Shares 347,036 Est. Cost $14.12 Unrealized —

— HARPOON THERAPEUTICS INC 2.9%

Value $4.871M Shares 428,400 Est. Cost $11.37 Unrealized —

AMLX AMYLYX PHARMACEUTICALS INC 2.4%

Value $4.059M Shares 275,773 Est. Cost $21.08 Unrealized -27.3%

PRAX PRAXIS PRECISION MEDICINES I 0.9%

Value $1.569M Shares 70,424 Est. Cost $18.01 Unrealized 0.0%

CMPX COMPASS THERAPEUTICS INC 0.8%

Value $1.302M Shares 834,630 Est. Cost $3.14 Unrealized -44.9%

— PROMIS NEUROSCIENCES INC 0.7%

Value $1.227M Shares 1,066,674 Est. Cost $1.56 Unrealized —

CNTX CONTEXT THERAPEUTICS INC 0.5%

Value $820K Shares 725,951 Est. Cost $0.88 Unrealized +22.2%

MDVLQ MEDAVAIL HOLDINGS INC 0.3%

Value $529K Shares 117,897 Est. Cost $10.12 Unrealized -62.3%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	JASPER THERAPEUTICS INC	3,659,255	$28.87M	17.2%	$2.48	—	COM	471871103
ARGX	ARGENX SE - ADR	35,000	$13.32M	7.9%	$380.43	—	SPONSORED ADR	04016X101
SLNO	SOLENO THERAPEUTICS INC	309,950	$12.48M	7.4%	$28.45	0.0%	COM	834203309
—	CYMABAY THERAPEUTICS INC	489,938	$11.57M	6.9%	$23.62	—	COM	23257D103
XENE	XENON PHARMACEUTICALS INC	241,961	$11.14M	6.6%	$36.94	-4.4%	COM	98420N105
—	INTRA-CELLULAR THERAPIES INC	141,348	$10.12M	6.0%	$52.09	—	COM	46116X101
OLMA	OLEMA PHARMACEUTICALS INC	659,035	$9.246M	5.5%	$13.44	0.0%	COM	68062P106
APLS	APELLIS PHARMACEUTICALS INC	150,000	$8.979M	5.4%	$43.93	+15.5%	COM	03753U106
MLTX	MOONLAKE IMMUNOTHERAPEUTICS	143,479	$8.665M	5.2%	$37.06	+39.1%	CLASS A ORD	61559X104
AXSM	AXSOME THERAPEUTICS INC	100,862	$8.028M	4.8%	$74.75	-10.6%	COM	05464T104
—	MERUS NV	274,923	$7.56M	4.5%	$20.59	—	COM	N5749R100
—	ALPINE IMMUNE SCIENCES INC	357,271	$6.81M	4.1%	$19.06	—	COM	02083G100
GERN	GERON CORP	2,971,639	$6.27M	3.7%	$2.61	-25.6%	COM	374163103
—	AMBRX BIOPHARMA INC	385,383	$5.488M	3.3%	$14.24	—	COM	641871108
—	AVADEL PHARMACEUTICALS-ADR	347,036	$4.9M	2.9%	$14.12	—	SPONSORED ADR	05337M104
—	HARPOON THERAPEUTICS INC	428,400	$4.871M	2.9%	$11.37	—	COM NEW	41358P205
AMLX	AMYLYX PHARMACEUTICALS INC	275,773	$4.059M	2.4%	$21.08	-27.3%	COM	03237H101
PRAX	PRAXIS PRECISION MEDICINES I	70,424	$1.569M	0.9%	$18.01	0.0%	COM NEW	74006W207
CMPX	COMPASS THERAPEUTICS INC	834,630	$1.302M	0.8%	$3.14	-44.9%	COM	20454B104
—	PROMIS NEUROSCIENCES INC	1,066,674	$1.227M	0.7%	$1.56	—	COM NEW	74346M406
CNTX	CONTEXT THERAPEUTICS INC	725,951	$820K	0.5%	$0.88	+22.2%	COM	21077P108
MDVLQ	MEDAVAIL HOLDINGS INC	117,897	$529K	0.3%	$10.12	-62.3%	COM NEW	58406B202